Company intelligence / Profile preview

Samsung Securities

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Samsung Securities is a leading South Korean securities and investment services firm providing brokerage, wealth and asset management, corporate finance, and capital markets services; it does not develop therapeutics or operate as a biotech, pharma, or healthcare company.[1][2]

Industry: Investors

Partnerships

RBC Dominion Securities (Canada)[2]Societe Generale (France)[2]Citic Securities (China)[2]SMBC Nikko Securities (Japan)[2]KGI Securities (Taiwan)[2]Hochimin Securities (Vietnam)[2]Woori Bank (Korea)[2]China AMC (Huaxia Fund)[2]Neuberger Berman[2]

Beyond the preview

Go deeper on Samsung Securities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Samsung Securities.

Explore the full profile